The Himalayan Cataract Project Custom Case Solution & Analysis

Evidence Brief: The Himalayan Cataract Project

1. Financial Metrics

Unit Cost: Cataract surgery performed for approximately 25 USD per patient in Nepal.
Component Pricing: Intraocular lenses (IOLs) produced at the Fred Hollows IOL Laboratory in Kathmandu cost less than 4 USD each, compared to global market rates exceeding 100 USD at the time of the case.
Revenue Model: Tiered pricing system where 30 percent of patients pay full price (approx. 100 USD), 20 percent pay a subsidized rate, and 50 percent receive surgery for free.
Surgical Efficiency: Surgeons perform a high-volume sutureless procedure in roughly 5 minutes.
Annual Reach: Over 180,000 surgeries performed annually across the network by the time of the expansion phase.

2. Operational Facts

Core Infrastructure: The Tilganga Institute of Ophthalmology (TIO) serves as the central hub for training, manufacturing, and high-complexity cases.
The Outreach Model: Mobile eye camps utilize high-volume surgical techniques (SICS) in remote areas without permanent infrastructure.
Manufacturing: Vertical integration through the Fred Hollows IOL Lab allows for independence from international medical supply price volatility.
Training Pipeline: HCP trains surgeons from over 20 countries, focusing on the specific manual small-incision cataract surgery (SICS) technique.
Geographic Scope: Initial success in Nepal led to expansion efforts in Ethiopia, Ghana, and Bhutan.

3. Stakeholder Positions

Dr. Sanduk Ruit: Co-founder and clinical lead. Developed the SICS technique. Focused on clinical excellence and cost reduction through local manufacturing.
Dr. Geoff Tabin: Co-founder and primary fundraiser. Focused on global advocacy, donor relations, and scaling the model to Sub-Saharan Africa.
Local Governments: Often provide physical space or regulatory approval but frequently lack the budget to fund the full cost of consumables.
International Donors: Provide capital for expansion but expect evidence of long-term financial self-sufficiency.

4. Information Gaps

African Unit Economics: The case does not provide a granular breakdown of the cost per surgery in Ethiopia or Ghana, which may differ from the 25 USD Nepal benchmark due to higher import duties or electricity costs.
Surgeon Retention Rates: Data on the long-term retention of HCP-trained surgeons within the public health systems of their home countries is absent.
Competition: Limited data on other NGOs or private providers operating in the same regions and their comparative cost structures.

Strategic Analysis

1. Core Strategic Question

Can the Himalayan Cataract Project replicate the surgical efficiency and financial self-sufficiency of the Nepal Tilganga model in Sub-Saharan Africa, where institutional support and supply chains are significantly weaker?

2. Structural Analysis

Value Chain Analysis: The HCP competitive advantage stems from vertical integration. By manufacturing lenses in-house, they eliminated the primary cost barrier to cataract surgery. However, this advantage is centralized in Nepal. Exporting the model to Africa requires either a secondary manufacturing hub or a highly efficient cross-continental supply chain.

Market Development: The project is moving from a high-trust, high-density environment (Nepal) to fragmented markets with lower surgeon-to-population ratios. The primary bottleneck is not demand (blindness is prevalent) but the supply of skilled labor capable of maintaining 5-minute surgical cycles without compromising safety.

3. Strategic Options

Option A: The Hub-and-Spoke Replication. Establish a flagship surgical and training institute in Ethiopia modeled exactly after Tilganga.
Trade-offs: Requires massive upfront capital and long-term political stability. It offers the highest quality control but slow geographic coverage.

Option B: The Asset-Light Training Model. Focus exclusively on training local surgeons in SICS and providing low-cost lenses, leaving facility management to local governments or partners.
Trade-offs: Lower capital expenditure but carries high risk of quality dilution and mismanagement by local partners.

Option C: Regional Manufacturing Expansion. Build a second IOL manufacturing plant in Sub-Saharan Africa to serve the continent.
Trade-offs: Solves the logistics and duty problem for the region but requires high technical expertise and a stable regulatory environment that may not yet exist.

4. Preliminary Recommendation

Pursue Option A (Hub-and-Spoke). The success in Nepal was predicated on the presence of a gold-standard facility that served as a center of excellence. Without a physical hub in Africa to anchor training and quality standards, the SICS technique will likely degrade in practice. Scaling must follow a phased approach: establish the Ethiopian hub first before expanding to West Africa.

Implementation Roadmap

1. Critical Path

Phase 1 (Months 1-6): Secure long-term land-use agreements and clinical accreditation with the Ethiopian Ministry of Health.
Phase 2 (Months 7-18): Construction of the central surgical hub and residency quarters. Simultaneously, begin the first cohort of African surgeons training at Tilganga in Nepal to prepare the initial workforce.
Phase 3 (Months 19-24): Launch the first 10 outreach camps in Ethiopia to build brand trust and clear the immediate surgical backlog.
Phase 4 (Year 3): Attain 30 percent private-pay patient volume to stabilize the cross-subsidization model.

2. Key Constraints

Talent Drain: High risk that surgeons trained by HCP will exit the nonprofit sector for private practice in urban centers or abroad.
Supply Chain Friction: Importation of surgical consumables into Sub-Saharan Africa involves unpredictable customs delays and high duties that threaten the 25 USD price point.

3. Risk-Adjusted Implementation Strategy

To mitigate the talent constraint, implementation must include mandatory service bonds for all HCP-trained residents. Regarding supply chain risks, the project should maintain a six-month inventory of lenses and sutures on-site in Ethiopia, rather than relying on just-in-time delivery from the Nepal factory. This increases holding costs but prevents facility downtime.

Executive Review and BLUF

1. BLUF

The Himalayan Cataract Project must prioritize the establishment of a regional center of excellence in Ethiopia to anchor its African expansion. The core of the Nepal success was not just the surgical technique, but the vertical integration of low-cost manufacturing and a self-sustaining cross-subsidization model. Replicating this requires a physical hub to maintain quality and train a local workforce. Failure to build this infrastructure will lead to a fragmented, low-quality outreach program that cannot scale. The goal is to reach 500,000 annual surgeries within five years by decentralizing training while centralizing quality control.

2. Dangerous Assumption

The analysis assumes that the 30 percent private-pay ratio achieved in Nepal is achievable in the Ethiopian and Ghanaian contexts. If the local middle class is smaller or has different healthcare preferences, the cross-subsidization model will collapse, leaving the project entirely dependent on external philanthropy.

3. Unaddressed Risks

Political Instability: Civil unrest in expansion regions could result in the total loss of physical assets and the displacement of the trained workforce. (Probability: High; Consequence: Extreme).
Technological Obsolescence: Rapid advances in laser-assisted surgery or pharmaceutical treatments could render the manual SICS technique less competitive or less desirable for paying patients. (Probability: Medium; Consequence: High).

4. Unconsidered Alternative

The team did not consider a licensing model where HCP sells the IOL manufacturing technology and SICS training modules to established global hospital chains already operating in Africa. This would remove the burden of facility management and capital expenditure from HCP, allowing them to focus on their core competency: clinical innovation and training.